Vertex Pharmaceuticals (VRTX) Long-Term Deferred Tax (2017 - 2026)
Vertex Pharmaceuticals (VRTX) reported Long-Term Deferred Tax of $1.95 billion for Q3 2026, down 33.5% from $2.94 billion a year earlier and down 35.1% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Long-Term Deferred Tax (2017 - 2026) Analysis & Trends
At the end of FY2025, Vertex Pharmaceuticals posted Long-Term Deferred Tax of $2.9 billion, up 24.3% from FY2024.
- Long-Term Deferred Tax has increased for five consecutive years, with a five-year compound annual growth rate of 26.8% (FY2020 to FY2025).
- By year, Long-Term Deferred Tax came in at $2.33 billion in FY2024 (+28.6%), $1.81 billion in FY2023 (+45.3%), $1.25 billion in FY2022 (+33.4%) and $934.5 million in FY2021 (+5.9%).
- The Q3 2026 figure ranks as the lowest quarterly Long-Term Deferred Tax since Q4 2023.
- Year over year, Long-Term Deferred Tax gained in seven of the last eight quarters, with growth averaging 15.9%.
- The high point for year-over-year Long-Term Deferred Tax in five years was Q3 2023 (growth of 48.7%); the low point was Q3 2026 (a decline of 33.5%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $3.01 billion (Q2 2026), $2.95 billion (Q1 2026) and $2.9 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.95 Bn |
| Jun 30, 2026 | 3.01 Bn |
| Mar 31, 2026 | 2.95 Bn |
| Dec 31, 2025 | 2.90 Bn |
| Sep 30, 2025 | 2.94 Bn |
| Jun 30, 2025 | 2.71 Bn |
| Mar 31, 2025 | 2.54 Bn |
| Dec 31, 2024 | 2.33 Bn |
| Sep 30, 2024 | 2.31 Bn |
| Jun 30, 2024 | 2.19 Bn |
| Mar 31, 2024 | 1.96 Bn |
| Dec 31, 2023 | 1.81 Bn |
| Sep 30, 2023 | 1.73 Bn |
| Jun 30, 2023 | 1.54 Bn |
| Mar 31, 2023 | 1.36 Bn |
| Dec 31, 2022 | 1.25 Bn |
| Sep 30, 2022 | 1.16 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 945.50 Mn |
| Dec 31, 2021 | 934.50 Mn |
API Access
Vertex Pharmaceuticals Long-Term Deferred Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-deferred-tax", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();